Navigation Links
Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
Date:1/13/2010

SALT LAKE CITY, Jan. 13 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) expects increases in pre-tax profits and net income for the quarter ended December 31, 2009.  Final results will be announced in the next few weeks.

Higher than expected sales in the month of December combined with reductions in expenses support the company's expectations of pre-tax profits in the range of $275,000 to $300,000 for the quarter ended December 31, 2009 compared to pre-tax profits of $89,917 for the quarter ended December 31, 2008.  Net income is expected to be approximately $170,000 to $185,000 for the quarter ended December 31, 2009 compared to net income of $54,598 for the quarter ended December 31, 2008.

"The second quarter is typically a strong sales and profit quarter for the company, but this exceeded our expectations," said Kelvyn H. Cullimore, chairman and president of Dynatronics. "Given the ongoing challenges to economic growth in the United States this increase in profitability over last year is very gratifying and indicative of improved operating efficiencies along with increased sales of high margin capital equipment."

"Looking ahead, we anticipate continued improvement in sales and net income from the expansion of our direct sales force and the preferred vendor agreements with large chains of clinics which were recently announced," added Cullimore.  "Our velocity continues to increase in a positive direction, and we expect this trend to continue."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding  increases in pre-tax profits and net income for the quarter ended December 31, 2009 and the expectation for continued improvement in sales and net income from the expansion of the company's direct sales force and the preferred vendor agreements with large chains of clinics.  Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2009.

SOURCE Dynatronics Corporation

RELATED LINKS
http://www.dynatronics.com

'/>"/>

SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
2. Dynatronics Receives 180-Day NASDAQ Extension
3. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
4. Dynatronics Announces Positive Financial Results for Quarter
5. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
6. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. The Foundry Announces Completion of Series A Financing for Twelfth Company
9. DATATRAK International, Inc. Announces Year-End Backlog
10. Stryker Corporation Announces Pricing of Senior Notes
11. Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)...  Sequent Medical, Inc. announced today that it has ... safety and effectiveness of the WEB™ Aneurysm Embolization System ... Prof Laurent Spelle , MD, Head of Neuroradiology ... and Principal Investigator of the CLARYS study, ... and Germany.  Although patients with ruptured aneurysms have ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... WILMINGTON, North Carolina , 12 februari ... Laboratories, Inc. (AAI/CML), een toonaangevende leverancier van ... farmaceutische en biotechnologische industrieën, kondigt vandaag een ... en mogelijkheden op haar locatie in ... in vraag heeft geleid tot meerdere recente ...
Breaking Medicine Technology:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Prater Eye Center becomes the first in the area to offer AngioPlex™ Optical ... signs of retinal disease, such as macular degeneration, diabetic retinopathy, and other vascular ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... Many individuals ... of protein for a multitude of reasons. IsoPasta by Isolator Fitness has delved ... it once more, but without the high-carb repercussions. IsoPasta has 30 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, ... gift of a VeinViewer® Vision vein finder for the nursing school ... an IV and draw blood, combining technology with traditional technique. , “VeinViewer is ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... According ... hernia surgeries are beginning to account for a significant portion of hernia repairs throughout ... Towfigh of the Beverly Hills Hernia Center notes that this trend has not only ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted over 250 members of South Florida’s philanthropic community at its 10th ...
Breaking Medicine News(10 mins):